SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 7, 2026

IMNM

Immunome Inc.
NEUTRAL
Impact 4/10
Horizonimmediate Processed4mo ago
Insider cluster: 2 insiders, $786K total
Actionable Insight • Neutral

The cluster is proportional to market cap (0.22%) and CMO sales aligned with derivative exercise are typical liquidity-driven events, not a strong bearish signal. Watch for any upcoming IMNM news (clinical data, financing) that might have motivated the accelerated selling by the Director.

DirectionNeutral
Confidencemedium
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$24.01
T+0 close · Jul 7, 2026 · via day close
Latest settled
−12.99%
T+60 · $20.89
Vs SPY
−15.49%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 8 $24.01entry
  2. T+1 · 4mo ago +0.67%α −0.18% · $24.17
  3. T+5 · 4mo ago −5.91%α −6.78% · $22.59
  4. T+20 · 3mo ago +6.29%α +3.02% · $25.52
  5. T+60 · 7w ago −12.99%α −15.49% · $20.89
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Immunome, Director Barchas and CMO Lechleider, collectively sold ~$6.0M of stock over the past week, with the largest executive sale occurring just after derivative exercises. At a $2.7B market cap, these sales represent ~0.22% of market cap, a modest but notable cluster.

Key Financial Metrics

Direction
selling
Total Value
$5.9M
Insiders
2

Key Facts

  • Director Isaac Barchas sold ~$4.7M total across three trades at $21.95–$24.20 per share (2026-07-02 through 2026-07-07).
  • CMO Robert Lechleider exercised 55,000 derivative shares at $0 cost (tax-free) and immediately sold ~55,000 shares for ~$1.24M in open-market trades at $21.95–$23.44 per share (2026-07-02).
  • Total cluster open-market sales: ~$5.9M (~0.22% of $2.7B market cap).
  • Prior 30d insider activity shows 8 sells totaling $8.0M, the recent cluster extends an ongoing selling pattern.

Financial Impact

~$5.9M in open-market sales, ~0.22% of $2.7B market cap, modest inside selling.

insider ownership percentage

Risk Factors

  • Insider selling may increase if a material adverse event is pending.
  • Director Barchas' $4.7M sell is the largest single-insider cash-out and may signal reduced conviction at current levels.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IMNM-1783465406249

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 7, 2026